
Press releases
Find out what's happening
Press releases
Read the latest statements and press releases from BAT and announcements about our key campaigns. If you need to contact our media relations team, please visit the Media contacts page.
We need more regulation says UK’s largest vapour manufacturer
BAT, the UK’s largest listed tobacco and vaping company, today launches a multi-pronged media campaign urging new regulations be introduced so the vaping industry can fulfil its potential to make smoke-free a reality in the UK.
Read more >BAT to Strengthen Strategic Partnership with Organigram
BAT subsidiary deepens strategic partnership with Organigram, investing c.£74m (CAD$124.6m) between January 2024 and January 2025 and increasing its equity position from c.19% to 45%
Read more >BAT Appoints Chief Financial Officer
Soraya Benchikh has been appointed to the role of Chief Financial Officer and Executive Director and will join the BAT p.l.c. and Management Boards from 1 May 2024.
Read more >BAT Appoints Chief People Officer to the Management Board
Cora Koppe-Stahrenberg, has been appointed to the new role of Chief People Officer and will join the BAT Management Board with effect from 1 November 2023.
Read more >BAT expresses disappointment at FDA Marketing Denial Order for Vuse Alto Menthol and Mixed Berry and will immediately seek a stay of enforcement
Today, BAT’s U.S. indirect subsidiary, R. J. Reynolds Vapor Company, received Marketing Denial Orders (MDOs) for Vuse Alto’s Menthol and Mixed Berry products. Vuse Alto Rich Tobacco and Golden Tobacco products remain under review with FDA.
Read more >Directorate Change
Murray S. Kessler will join the Board of British American Tobacco p.l.c. as an independent Non-Executive Director and member of the Nominations and Remuneration Committees with effect from 6 November 2023.
Read more >BAT outlines five-step plan towards better regulation of vapour sector
Kingsley Wheaton, BAT’s Chief Strategy & Growth Officer, called for a smarter regulatory framework for vapour products to help governments worldwide deliver on their aims for a Smokefree 2030 in remarks as the Global Tobacco & Nicotine Forum 2023 (GTNF) kicked off today
Read more >Russia business update – sale completed
Further to our announcement on 7 September 2023, we have now completed the sale of our Russian and Belarusian businesses.
Read more >Russia business update – agreement signed
BAT has now formally entered into an agreement to sell its Russian and Belarusian businesses in compliance with local and international laws.
Read more >Half-Year Report for the six months to 30 June 2023
Half-Year Report for the six months to 30 June 2023
Read more >BAT announces changes to Management Board structure and composition
Following the appointment of Tadeu Marroco as Chief Executive on 15 May 2023, BAT announces changes to its Management Board.
Read more >2023 First Half Pre-Close Trading Update
2023 H1 Pre-Close Trading Update: On track to meet full year guidance
Read more >New clinical data on Vuse illustrates beneficial public health impact of Tobacco Harm Reduction
New clinical data on Vuse illustrates beneficial public health impact of Tobacco Harm Reduction
Read more >BAT announces Tadeu Marroco as Chief Executive
The Board announces the appointment of Tadeu Marroco as Chief Executive of BAT plc to succeed Jack Bowles who is stepping down from the Board of Directors with effect from 15 May.
Read more >BAT reaches agreement with U.S. Department of Justice (DOJ) and U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC)
Agreement reached with DOJ and OFAC to resolve investigations into BAT’s historical business activities in relation to North Korea from 2007-2017 BAT ceased all business activities related to North Korea by September 2017 No impact on Full Year 2023 Group guidance; investigations previously disclosed and provisions made in 2022 Half Year Report
Read more >Marketing Denial Order issued for Vuse Solo Menthol 4.8%
Today, U.S. Food and Drug Administration (“FDA”) has issued a Marketing Denial Order (“MDO”) for Vuse Solo’s 4.8% Menthol product.
Read more >Preliminary announcement - year ended 31 December 2022
Preliminary Results 2022 - quote
Read more >BAT included in prestigious 2023 Bloomberg Gender-Equality Index
BAT included in 2023 Bloomberg Gender-Equality Index in first year participating; recognises BAT’s efforts to sustain a diverse, inclusive culture.
Read more >Driving Faster Transformation at BAT: Management Board changes and a new regional structure
Following a strategic review of its regions, business units and global functions, BAT will implement a number of senior management changes and a new regional structure to both streamline, and accelerate, the transformation of its business.
Read more >MDO for Vuse Vibe Tank Menthol 3.0% and Vuse Ciro Cartridge Menthol 1.5%
Today, U.S. Food and Drug Administration (“FDA”) has issued Marketing Denial Orders (“MDOs”) for two Vuse products—the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%.
Read more >BAT recognised as a Global Top Employer for a sixth consecutive year
BAT is pleased to be certified as a Global Top Employer for a sixth successive year. We are accredited as a Global Top Employer for 2023 across three regions – Africa, Asia Pacific and Europe.
Read more >You might also be interested in
Video: Chief Executive’s take on HYR 2023
Our Chief Executive Tadeu Marroco shares his views on BAT’s Half-Year Results for the six months to 30 June 2023.
Read more >